Trichloroethylene does not accelerate autoimmune diabetes in NOD mice

Journal of Immunotoxicology

Volumn 1, Issue 3-4, 2005, Pages 141-148

  Ravel, Guillaume ^a,b   Christ, Marielle ^b   Perron Lepage, Marie France ^b   Condevaux, Fabienne ^b   Descotes, Jacques ^a  

^a Poison Center   (France)

^b MDS Pharma Services   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052613711     PISSN: 1547691X     EISSN: None     Source Type: Journal    
DOI: 10.1080/15476910490916044     Document Type: Article

References (44)

1. Adorini, L., Gregori, S., and Harrison, L. C. 2002. Understanding autoimmune diabetes: Insights from mouse models. Trends Mol. Med. 8:31-38.
2. ATSDR. 1997. Toxicological profile for trichloroethylene (Update). Atlanta, NC: Agency for Toxic Substance Substances and Disease Registry. Public Health Service, U. S. Department of Health and Human Services.
3. Aryal, B. K., Khuder, S. A., and Schaub, E. A. 2001. Meta-analysis of systemic sclerosis and exposure to solvents. Am. J. Ind. Med. 40:271-274.
4. Bovenzi, M., Barbone, F., Betta, A., Tommasini, M., and Versini, W. 1995. Scleroderma and occupational exposure. Scand. J. Work Environ. Health 21:289-292.
5. Brenden, N., Rabbani, H., and Abedi-Valugerdi, M. 2001. Analysis of mercuryinduced immune activation in nonobese diabetic (NOD) mice. Clin. Exp. Immunol. 125:202-210.
6. + T-lymphocytes. Immunology 99:394-401.
7. Cooper, G. S., Miller, F. W., and Germolec, D. R. 2002. Occupational exposures and autoimmune diseases. Int. Immunopharmacol. 2:303-313.
8. Cummings, B. S., Parker, J. C., and Lash, L. H. 2001. Cytochrome p450-dependent metabolism of trichloroethylene in rat kidney. Toxicol. Sci. 60:11-19.
9. Dubey, C., and Croft M. 1996. Accessory molecule regulation of naive CD4 T-cell activation. Immunol. Res. 15:114-125.
10. Garabrant, D. H., Lacey, J. V., Laing, T. J., Gillespie, B. W., Mayes, M. D., Cooper, B. C., and Schottenfeld, D. 2003. Scleroderma and solvent exposure among women. Am. J. Epidemiol. 157:493-500.
11. + T-cells: Potential role in an autoimmune response. Drug Metab. Rev. 31:901-916.
12. +/+ mice. Immunopharmacology 46:123-137.
13. +/+ mice. Toxicol. Sci. 57:345-352.
14. +/+ mice. Toxicol. Sci. 54:384-389.
15. Halmes, N. C., McMillan, D. C., Oatis, J. E. Jr., and Pumford, N. R. 1996. Immunochemical detection of protein adducts in mice treated with trichloroethylene. Chem. Res. Toxicol. 9:451-456.
16. Haynes, B. F., Telen, M. J., Hale, L. P., and Denning, S. M. 1989. CD44-a molecule involved in leukocyte adherence and T-cell activation. Immunol. Today 10:423-428.
17. Hess E. V. 2002. Environmental chemicals and autoimmune disease: Cause and effect. Toxicology 181-182:65-70.
18. Kaneko, T., Saegusa, M., Tasaka, K., and Sato, A. 2000. Immunotoxicity of trichloroethylene: A study with MRL-lpr/lpr mice. J. Appl. Toxicol. 20:471-475.
19. Kauffmann, B. M., White, K. L., Sanders, V. M., Douglas, K. A., Sain, L. E., Borzelleca, J. F., and Munson, A. E. 1982. Humoral andcell-mediated immune status in mice exposed to chloral hydrate. Environ. Health Perspect. 44:147-151.
20. +/+ mice. Toxicol. Appl. Pharmacol. 134:155-160.
21. Kilburn, K. H., and Warshaw, R. H. 1992. Prevalence of symptoms of systemic lupus erythematosus (SLE) and of fluorescent antinuclear antibodies associated with chronic exposure to trichloroethylene and other chemicals in well water. Environ. Res. 57:1-9.
22. Kukreja, A., and Maclaren, N. K. 1999. Autoimmunity and diabetes. J. Clin. Endocrinol. Metab. 84:4371-4378.
23. Lash, L. H., Fisher, J. W., Lipscomb, J. C., and Parker, J. C. 2000. Metabolism of trichloroethylene. Environ. Health Perspect. 108:177-200.
24. 2 cells: A historical perspective. Nat. Rev. Immunol. 2:55-60.
25. Martin, S., van den Engel, N. K., Vinke, A., Heidenthal, E., Schulte, B., and Kolb, H. 2001. Dominant role of intercellular adhesion molecule-1 in the pathogenesis of autoimmune diabetes in non-obese diabetic mice. J. Autoimmun. 17:109-117.
26. Mizugaki, M., Yamaguchi, T., Ishiwata, S., Shindo, H., Hishinuma, T., Nozaki, S., and Nose M. 1997. Alteration of DNA methylation levels in MRL lupus mice. Clin. Exp. Immunol. 110:265-269.
27. Morahan, G., and Morel, L. 2002. Genetics of autoimmune diseases in humans and animal models. Curr. Opin. Immunol. 14:803-811.
28. Nietert, P. J., Sutherland, S. E., Silver R. M., Pandey, J. P., Knapp, R. G., Hoel, D. G., and Dosemeci, M. 1998. Is occupational organic solvent exposure a risk factor for scleroderma? Arthritis Rheum. 41:1111-1118.
29. O'Shea, J. J., Ma, A., and Lipsky, P. 2002 Cytokines and autoimmunity. Nat. Rev. Immunol. 2:37-45.
30. Pollard, K. M., Pearson, D. L., Hultman, P., Hildebrandt, B., and Kono, D. H. 1999. Lupus-prone mice as models to study xenobiotic-induced acceleration of systemic autoimmunity. Environ. Health Perspect. 107(suppl 5):729-735.
31. Rabinovitch, A. 1998. An update on cytokines in the pathogenesis of insulindependent diabetes mellitus. Diabetes. Metab. Rev. 14:129-151.
32. Roncarolo, M. G., and Levings, M. K. 2000. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr. Opin. Immunol. 12:676-683.
33. Rosmalen, J. G., van Ewijk, W., Leenen, P. J. 2002. T-cell education in autoimmune diabetes: Teachers and students. Trends Immunol. 23:40-46.
34. Sanders, V. M., Tucker, A. N., White, K. L., Kauffmann, B. M., Hallett, P., Carchman, R. A., Borzelleca, J. F., and Munson, A. E. 1982. Humoral and cellmediated immune status in mice exposed to trichloroethylene in the drinking water. Toxicol. Appl. Pharmacol. 62:358-368.
35. Savinov, A. Y., Tcherepanov, A., Green, E. A., Flavell, R. A., and Chervonsky, A. V. 2003. Contribution of Fas to diabetes development. Proc. Natl. Acad. Sci. USA 100:628-632.
36. Shimada, A., Charlton, B., Rohane, P., Taylor-Edwards, C., and Fathman, C. G. 1996a. Immune regulation in type 1 diabetes. J. Autoimmun. 9:263-269.
37. + cells correlate with cytokine profiles in the spontaneously autoimmune diabetic mouse. Diabetes 45:71-78.
38. Suk, K., Kim, S., Kim, Y H., Kim, K. A., Chang, I. Yagita, H., Shong, M., and Lee, M. S. 2001. IFN-γ/TNF-α synergism as the final effector in autoimmune diabetes: A key role for STAT1/IFN regulatory factor-1 pathway in pancreatic β cell death. J. Immunol. 166:4481-4489.
39. Tao, L., Kramer, P. M., Ge, R., and Pereira, M. A. 1998. Effect of dichloroacetic acid and trichloroacetic acid on DNA methylation in liver and tumors of female B6C3F1 mice. Toxicol. Sci. 43:139-144.
40. Tao, L., Yang, S., Xie, M., Kramer, P. M. and Pereira, M. A. 2000. Effect of trichloroethylene and its metabolites, dichloroacetic acid and trichloroacetic acid, on the methylation and expression of c-Jun. and c-Myc protooncogenes in mouse liver: Prevention by methionine. Toxicol. Sci. 54:399-407.
41. Weiss, L., Slavin, S., Reich, S., Cohen, P., Shuster, S., Stern, R., Okon, E., Rubinstein, A. M., and Naor, D. 2000. Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc. Natl. Acad. Sci. USA 97:285-290.
42. White, K. L., David, D. W., Butterworth, L. F., and Klykken, P. C. 2000. Assessment of autoimmunity-inducing potential using the Brown Norway rat challenge model. Toxicol. Lett. 112-113:443-551.
43. Wright, P. F., Thomas, W D., and Stacey, N. H. 1991. Effects of trichloroethylene on hepatic and splenic lymphocytotoxic activities in rodents. Toxicology 70:231-242.
44. Yadav, D., and Sarvetnick, N. 2003. Cytokines and autoimmunity: Redundancy defines their complex nature. Curr. Opin. Immunol. 15:697-703.